JCIA
RGNX icon

Jackson Creek Investment Advisors’s Regenxbio RGNX Stock Holding History

Jackson Creek Investment Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,884
Closed -$1.09M – 361
2022
Q1 		$1.09M Buy
32,884
+2,313
+8% +$64.3K 0.4% 104
2021
Q4 		$1M Buy
+30,571
New +$1.04M 0.36% 150

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Jackson Creek Investment Advisors's RGNX Position: Q2 2022 in Review

Jackson Creek Investment Advisors sold out of Regenxbio (RGNX) in Q2 2022, closing a stake of 32,884 shares — an estimated $1.09M sold.

Jackson Creek Investment Advisors first reported a position in RGNX in Q4 2021 and held it in 2 quarters. The position peaked at $1.09M in Q1 2022. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2022.

  • Jackson Creek Investment Advisors reported no remaining Regenxbio position as of Q2 2022 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 32,884 Regenxbio shares in Q2 2022, an estimated $1.09M.
  • Jackson Creek Investment Advisors first reported a position in Regenxbio in Q4 2021 and held it in 2 quarters.
  • Jackson Creek Investment Advisors's Regenxbio position peaked at $1.09M in Q1 2022.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2022.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2022, filed 4 Aug 2022.